SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 250 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,368,000 | +48.7% | 34,204 | +16.3% | 0.05% | +108.0% |
| Q1 2017 | $920,000 | +197.7% | 29,400 | +135.2% | 0.02% | +316.7% |
| Q3 2016 | $309,000 | -70.2% | 12,500 | -83.1% | 0.01% | -85.0% |
| Q3 2015 | $1,038,000 | -52.4% | 74,005 | -42.3% | 0.04% | -28.6% |
| Q2 2015 | $2,179,000 | +125.3% | 128,300 | +60.4% | 0.06% | +107.4% |
| Q1 2015 | $967,000 | +86.7% | 80,000 | +28.2% | 0.03% | +42.1% |
| Q4 2014 | $518,000 | – | 62,400 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |